Registry Study on Control Nocturnal Hypertension to Reach the Target (CONTROL-NHT)

What this Trial Is About

Ambulatory blood pressure monitoring (ABPM) has become an important tool for diagnosing hypertension by measuring blood pressure throughout daily activities and sleep. This research focuses on the significance of nocturnal blood pressure, which has been found to better predict fatal and non-fatal cardiovascular events like stroke and heart attack, especially in patients on medication. The study aims to understand how controlling nighttime blood pressure affects cardiovascular outcomes in patients with nocturnal hypertension. The study collects nationwide prospective data on patients diagnosed with nocturnal hypertension who are using antihypertensive drugs. Participants have undergone 24-hour ABPM with validated equipment to confirm elevated nighttime blood pressure. The research involves monitoring participants over time to compare cardiovascular event rates based on how well their nocturnal blood pressure is controlled. Participants will be followed for up to three years, during which researchers will record the time to any fatal or non-fatal cardiovascular event. The study requires participants to provide medical history and biochemical test results within six months and to consent to the study. This long-term observation will help assess the impact of nighttime blood pressure management on heart health and stroke risk.

Registry Study on "Control Nocturnal Hypertension to Reach the Target "